13.14

2.02% 0.26

After Hours: 13.08 -0.06 -0.46%

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $13.14, with a volume of 1.21M. It is up +2.02% in the last 24 hours and up +16.80% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$12.88

Open:

$13

24h Volume:

1.21M

Relative Volume:

0.89

Market Cap:

$608.97M

Revenue:

$217.11M

Net Income/Loss:

$-651.19M

P/E Ratio:

-1.0115

EPS:

-12.99

Net Cash Flow:

$-387.26M

1W Performance:

-11.81%

1M Performance:

+16.80%

6M Performance:

-1.65%

1Y Performance:

-13.55%

1-Day Range:

$12.82

$13.63

1-Week Range:

$12.56

$15.06

52-Week Range:

$5.00

$16.85

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1161)

Industry

Biotechnology (646)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

834

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	13.14	753.89M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	456.87	120.48B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	545.46	59.88B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	392.24	44.31B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	670.33	36.65B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	301.13	32.46B	3.81B	-644.79M	-669.77M	-6.24

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

Jul 31, 2025

Ginkgo Bioworks awarded $4.66M contract by PNNL - Yahoo Finance

Jul 31, 2025

Ginkgo Bioworks Q2 Earnings: Biosecurity Leader Sets August 7 Investor Call with Interactive Q&A - Stock Titan

Jul 31, 2025

How does Ginkgo Bioworks Holdings Inc. compare to its industry peersWealth Building Guidance For Smart Trading - jammulinksnews.com

Jul 31, 2025

Does Ginkgo Bioworks Holdings Inc. stock perform well during market downturnsSmart Portfolio Planner For Beginners - jammulinksnews.com

Jul 31, 2025

Jul 30, 2025

Ginkgo Bioworks stock rises after securing $4.66M automation contract By Investing.com - Investing.com Canada

Jul 30, 2025

Ginkgo Bioworks Secures $4.66M Federal Contract for Revolutionary Lab Automation System at PNNL - Stock Titan

Jul 30, 2025

Jul 29, 2025

What makes Ginkgo Bioworks Holdings Inc. stock price move sharplyRisk Managed Intraday Trade Alerts Increase in Volume - metal.it

Jul 29, 2025

Ginkgo Bioworks Holdings Inc. Flashes Rebound Signal in Oversold ConditionInvestment Plan With Growth Optimization Finalized - metal.it

Jul 29, 2025

Ginkgo Bioworks Holdings Inc. Stock Flags Risk Zone in Volatility IndexEarly Breakout Entry Point Notifications Sent - beatles.ru

Jul 29, 2025

Jul 28, 2025

Ginkgo Bioworks Holdings Inc. Breaks Below Key Support LevelSecure Capital Picks With Upside Potential Tracked - metal.it

Jul 28, 2025

What are analysts’ price targets for Ginkgo Bioworks Holdings Inc. in the next 12 monthsMaximize gains with proven stock analysis - jammulinksnews.com

Jul 28, 2025

What is the dividend policy of Ginkgo Bioworks Holdings Inc. stockSwing Trade Updates For Consistent Profits - jammulinksnews.com

Jul 28, 2025

How strong is Ginkgo Bioworks Holdings Inc. company’s balance sheetStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025

When is Ginkgo Bioworks Holdings Inc. stock expected to show significant growthTop Growth Watchlist For 2025 - jammulinksnews.com

Jul 28, 2025

What are the latest earnings results for Ginkgo Bioworks Holdings Inc.Achieve rapid portfolio appreciation today - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What catalysts could drive Ginkgo Bioworks Holdings Inc. stock higher in 2025High-octane financial growth - jammulinksnews.com

Jul 27, 2025

What institutional investors are buying Ginkgo Bioworks Holdings Inc. stockAchieve rapid wealth accumulation through smart investing - jammulinksnews.com

Jul 27, 2025

Should I hold or sell Ginkgo Bioworks Holdings Inc. stock in 2025Accelerated capital growth - jammulinksnews.com

Jul 27, 2025

Ginkgo Bioworks Stock (DNA) Opinions on New Product Launch and Earnings Anticipation - Quiver Quantitative

Jul 27, 2025

Why Ginkgo Bioworks Holdings Inc. stock attracts strong analyst attentionEarly Breakout Tracker - beatles.ru

Jul 27, 2025

Jul 25, 2025